A plausible explanation could be a reorientation of Lys105 towards GS resulting in a decreased stabilization of the active site thiolate as a leaving group
It is currently the phase II drug associated with the greatest weight reduction, achieving a 24% decrease (28.5% in women) after 48 weeks with a weekly dose of 12 mg55 (Table 1), and providing significant benefits in the control of cardiovascular risk factors and the reduction of MASLD56 (Fig
For most people, GLP-1s are safe, but its essential to take them under medical supervision
Adherence, Persistence, and Patient Experience Even when patients overcome access barriers and initiate treatment, the next challenge is staying on therapy long enough to achieve meaningful and sustained outcomes
15 If patients screen positive for AUD, they should undergo evaluation using DSM-5 ( Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition ) criteria (Table 2)